COLOMBO NICOLETTA

De Vitis, L., Schivardi, G., Delfrati, S., Biffi, B., Viscardi, A., Rosanu, M., et al. (2025). The prognostic impact of molecular classification in endometrial cancer that undergoes fertility-sparing treatment. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 35(1) [10.1016/j.ijgc.2024.100024]. Detail

Fumagalli, D., Jayraj, A., Olearo, E., Capasso, I., Hsu, H., Tzur, Y., et al. (2025). Erratum to ‘Primary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer’ [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101664] (International Journal of Gynecological Cancer (2025) 35(3), (S1048891X25001896), (10.1016/j.ijgc.2025.101664)) [Altro] [10.1016/j.ijgc.2025.101952]. Detail

Poveda, A., Lheureux, S., Colombo, N., Cibula, D., Elstrand, M., Weberpals, J., et al. (2025). Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trial. GYNECOLOGIC ONCOLOGY, 197(June 2025), 74-82 [10.1016/j.ygyno.2025.04.580]. Detail

Scambia, G., Villalobos Valencia, R., Colombo, N., Cibula, D., Leath, C., Bidzinski, M., et al. (2025). Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results. JOURNAL OF CLINICAL ONCOLOGY, 43(12), 1408-1416 [10.1200/JCO.24.00933]. Detail

Fumagalli, D., Jayraj, A., Olearo, E., Capasso, I., Hsu, H., Tzur, Y., et al. (2025). Primary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 35(3) [10.1016/j.ijgc.2025.101664]. Detail